Department of Cardiology, IBSAL-University Hospital, CIVER-CV, Universidad de Salamanca, Salamanca, Spain.
Department of Cardiology, IBSAL-University Hospital, CIVER-CV, Universidad de Salamanca, Salamanca, Spain.
Am J Cardiol. 2020 Dec 1;136:87-93. doi: 10.1016/j.amjcard.2020.09.010. Epub 2020 Sep 16.
Although radiofrequency catheter ablation (RFCA) is indicated in electrical storm (ES) refractory to antiarrhythmic drugs, its most appropriate timing has not been determined. Our objective is to analyse the impact of the timing of RFCA on 30-day mortality in patients with ES and previous scar-related systolic dysfunction. In this multi-centre study, we analysed 104 patients (age: 72 ± 10, left ventricular ejection fraction: 30 ± 6%) attended consecutively due to an ES caused by monomorphic ventricular tachycardia. Sixty-four subjects were treated with RFCA (mean time from admission = 83 ± 67 hours) and 40 were not. Upon admission 25 (24%) individuals had severe heart failure. Mortality rate at 30 days was 24 (23%) patients. RFCA was associated with a reduction of 30-day mortality (hazard ratio = 0.2; p = 0.008). After showing a positive correlation between the time of the RFCA (hours) and survival at 30 days (C-statistic = 0.77; p <0.001), we found that only subjects ablated >48 hours after admission had lower mortality at 30 days than those treated conservatively: 38% (no RFCA) versus 30% (RFCA ≤48 hours) versus 7% (RFCA >48 hours) (adjusted hazard ratio for RFCA >48 hours vs others = 0.2; p = 0.007). Among the patients ablated, those who were non-inducible had lower 30-day mortality: 8% versus 29% (p = 0.03). Extracorporeal membrane oxygenation was associated with a higher rate of non-inducibility in RFCA >48 hours (100% vs 76%; p = 0.03), but not in RFCA ≤48 hours (60% vs 60%; p = 1). In conclusion, among high-risk patients with ES, RFCA performed >48 hours after admission is associated with a reduction in 30-day mortality. In such subjects, the probability of successful RFCA increases when performed under extracorporeal membrane oxygenation support.
尽管射频导管消融 (RFCA) 适用于对抗心律失常药物无效的电风暴 (ES),但其最合适的时机尚未确定。我们的目的是分析 RFCA 时机对 ES 合并先前瘢痕相关收缩功能障碍患者 30 天死亡率的影响。在这项多中心研究中,我们分析了 104 例因单形性室性心动过速引起的 ES 连续就诊的患者 (年龄:72 ± 10 岁,左心室射血分数:30 ± 6%)。64 例患者接受了 RFCA 治疗 (平均入院时间为 83 ± 67 小时),40 例未接受治疗。入院时,25 例 (24%)患者有严重心力衰竭。30 天死亡率为 24 例 (23%)患者。RFCA 与 30 天死亡率降低相关 (风险比=0.2;p=0.008)。在显示 RFCA 时间 (小时)与 30 天生存时间之间存在正相关 (C 统计量=0.77;p<0.001)后,我们发现仅在入院后 >48 小时进行消融的患者在 30 天死亡率低于保守治疗者:38% (无 RFCA) 与 30% (RFCA ≤48 小时) 与 7% (RFCA >48 小时) (校正后的 RFCA >48 小时与其他因素的风险比为 0.2;p=0.007)。在接受消融治疗的患者中,非诱发性患者的 30 天死亡率较低:8% 与 29% (p=0.03)。体外膜肺氧合与 RFCA >48 小时时非诱发性发生率较高相关 (100% 比 76%;p=0.03),但与 RFCA ≤48 小时时无关 (60% 比 60%;p=1)。总之,在 ES 高危患者中,入院后 >48 小时进行 RFCA 与 30 天死亡率降低相关。在这些患者中,在体外膜肺氧合支持下进行 RFCA 可提高成功率。